BLT SKIN CREAM- benzocaine, lidocaine, tetracaine cream 
M2B Pharma LLC

----------

BLT Skin Cream

DRUG FACTS

Active ingredient

Benzocaine 20%

Purpose

Topical anesthetic

Active ingredient

Lidocaine 4%

Purpose

Topical analgesic

Active ingredient

Tetracaine 1%

Purpose

Topical analgesic

Uses

For temporary relief of pain

Warnings

For external use only

Do not use

  • On wounds or damaged, broken or irritated skin
  • In large quantities
  • At the same time as other topical analgesics or anesthetics
  • If you are currently taking medication to control heart rate or rhythm or if you have any type of heart disease
  • If you are allergic to PABA, benzocaine, lidocaine, tetracaine or other sulfonamides (sulfa) type drugs
  • If you are under the age of 17

When using this product

  • Use only as directed. Read and follow all directions and warnings on this label.
  • Avoid contact with eyes or mucous membrane
  • Do not bandage or cover with any type of clear occlusive dressing
  • Do not apply local heat (such as heating pad) to area of use

Stop use and ask a doctor if

  • If redness or skin irritation is present at application site
  • Condition worsens
  • Symptoms persist for more than 7 days or clear up and occur again within a few days
  • You have any heart conditions

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Adults and children over 17 years of age:

Do not use on children 17 years and younger without consulting a doctor.

Other Information

Inactive Ingredients

behentrimonium chloride, caprylic/capric triglyceride, cetearyl alcohol, citric acid, dimethyl isosorbide, ethylhexylglycerin, PEG-150 distearate, phenoxyethanol, polyquaternium-37, water

Questions?

1-877-760-1881

www.bltskincream.com

Principal Display Panel

label1

label2

bltbox

BLT SKIN CREAM 
benzocaine, lidocaine, tetracaine cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73341-001
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE0.2 g  in 1 g
TETRACAINE (UNII: 0619F35CGV) (TETRACAINE - UNII:0619F35CGV) TETRACAINE0.01 g  in 1 g
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE0.04 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
DIMETHYL ISOSORBIDE (UNII: SA6A6V432S)  
POLYQUATERNIUM 37 (200 MPA.S) (UNII: 67C1D6YV24)  
BEHENTRIMONIUM CHLORIDE (UNII: X7GNG3S47T)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
WATER (UNII: 059QF0KO0R)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
PEG-150 DISTEARATE (UNII: 6F36Q0I0AC)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73341-001-3030 g in 1 JAR; Type 0: Not a Combination Product02/04/2020
2NDC:73341-001-01454 g in 1 JAR; Type 0: Not a Combination Product12/23/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01702/04/2020
Labeler - M2B Pharma LLC (117182771)

Revised: 10/2023
Document Id: 087972ab-146e-3a62-e063-6394a90acf46
Set id: 9dc5db9d-9e0a-cd28-e053-2995a90a6bf7
Version: 7
Effective Time: 20231024
 
M2B Pharma LLC